A summary of current health news details EU regulators probing Novo Nordisk's $16.5 billion Catalent takeover, Amgen's ...

Good day and welcome to the FibroGen third-quarter 2024 earnings conference call. (Operator Instructions) Please note this event is being recorded. I would now like to hand the call over to David ...

Merck & Co (MSD), Alexion, and AstraZeneca Rare Disease have reported positive topline outcomes from the Phase III KOMET ...

A European Union court upheld the bloc's decision to approve Vodafone's acquisition of some of Liberty Global's telecommunications assets, thwarting a legal challenge from German telecom rivals.

KOMET phase III trial of Koselugo shows statistically significant and clinically meaningful ORR vs. placebo in adults with neurofibromatosis type 1: Cambridge, UK Wednesday, Novem ...

The company has also secured strategic partnerships with AstraZeneca for drug development and Ansys for ... including the U.S ...

AstraZeneca has announced $3.5bn in capital investment aimed at expanding its US research and manufacturing capabilities by ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

Investing.com - European stock markets retreated Tuesday as investors digested fresh regional employment and inflation data ...

Consumers started their Christmas shopping early, Kantar says; UK jobless rate rises to 4.3% while wage growth excluding ...

Italian authorities say they have dismantled a network of European art forgers who made fake Warhols, Banksys and Picassos ...

Azerbaijan's oil and gas revenues accounted for 35 per cent of its economy in 2023, down from 50 per cent two years earlier.